CIK 0001527728 · Non-accelerated filer<br>Smaller reporting company
Lunai Bioworks Inc.
Sign in to watch- Ticker
- LNAI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452259340
- Phone
- 45 39179840
- Business address
- CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CA, 90067
- Former names
- RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-06 | Alton Gregg H Director | Grant or award · Option to purchase shares of common stock | +15,625 | 15,625 | ||
| 2020-04-06 | Brosgart Carol L Director | Grant or award · Option to purchase shares of common stock | +15,625 | 15,625 | ||
| 2020-01-07 | Puche Luisa Chief Financial Officer | Option exercise | +5,000 | 5,000 | ||
| 2020-01-07 | Puche Luisa Chief Financial Officer | Option exercise · Restricted Stock Units | −5,000 | 10,000 | ||
| 2019-08-22 | Sindlev Rene Director | Grant or award · Option to purchase shares of common stock | +3,346 | 3,346 | ||
| 2019-08-22 | Sandler Carl Forest Jr Director | Grant or award · Option to purchase shares of common stock | +8,248 | 8,248 | ||
| 2019-08-22 | Gronfeldt-Sorensen Henrik Director | Grant or award · Option to purchase common stock | −7,759 | 7,759 | ||
| 2019-08-22 | D An Evelyn Director | Grant or award · Option to Purchase Common Stock | +9,173 | 9,173 | ||
| 2019-08-22 | SAPIRSTEIN JAMES Director | Grant or award · Option to Purchase Common Stock | +9,173 | 9,173 | ||
| 2019-07-30 | Weird Science LLC 10% owner | Other acquisition | +3,631,234 | 22,445,397 | ||
| 2019-07-30 | Sandler Carl Forest Jr Director | Other acquisition | +3,631,234 | 22,445,397 | ||
| 2019-07-30 | Dybul Mark Executive Vice Chair | Other acquisition | +10,680 | 66,016 | ||
| 2019-07-30 | Sindlev Rene Director | Option exercise | +3,092,307 | $1.30 | $4.0M | 9,668,351 |
| 2019-07-30 | Sindlev Rene Director | Option exercise · Warrant (right to buy) | +3,092,307 | $1.30 | $4.0M | 0 |
| 2019-06-09 | Puche Luisa Chief Financial Officer | Other disposition · Restricted Stock Units | −15,000 | $6.15 | $92K | 0 |
| 2019-06-06 | Puche Luisa Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +60,000 | $6.15 | $369K | 60,000 |
| 2019-06-06 | Puche Luisa Chief Financial Officer | Grant or award · Restricted Stock Units | +15,000 | $6.15 | $92K | 15,000 |
| 2019-06-04 | Sindlev Rene Director | Purchase | +31,500 | $6.70 | $211K | 6,576,044 |
| 2019-06-03 | Sindlev Rene Director | Purchase | +40,000 | $6.70 | $268K | 6,544,544 |
| 2019-05-29 | Sindlev Rene Director | Purchase | +20,000 | $6.60 | $132K | 6,504,544 |
Page 8 of 10 · 198 trades